Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET
- 2 March 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 69 (1), 79-88
- https://doi.org/10.1016/j.jhep.2018.02.014
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Conflicting Roles of Molecules in Hepatocarcinogenesis: Paradigm or ParadoxCancer Cell, 2012
- Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor developmentProceedings of the National Academy of Sciences of the United States of America, 2011
- Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell poolBlood, 2011
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 ActivationCancer Cell, 2010
- Distinct pathways of genomic progression to benign and malignant tumors of the liverProceedings of the National Academy of Sciences of the United States of America, 2007
- PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphataseBlood, 2006
- Concerted Functions of Gab1 and Shp2 in Liver Regeneration and HepatoprotectionMolecular and Cellular Biology, 2006
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Downregulation of platelet-derived growth factor receptor-β in Shp-2 mutant fibroblast cell linesOncogene, 1998